Costa Laurence Bedin da, Toneto Marcelo Garcia, Moreira Luis Fernando
Postgraduate Program in Medicine, Surgical Sciences, Universidade Federal do Rio Grande do Sul; RS, Brazil.
Department of Surgery, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul; RS, Brazil.
Arq Bras Cir Dig. 2016 Nov-Dec;29(4):232-235. doi: 10.1590/0102-6720201600040005.
Although the incidence of gastric (adenocarcinoma) cancer has been decreasing over time, it is still one of the most common malignancies worldwide, and proximal tumours tend to have a worse prognosis.
To compare surgical outcomes and prognosis between proximal - excluding tumours of the cardia - and distal gastric cancer.
Out of 293 cases reviewed - 209 with distal and 69 with proximal gastric cancer - were compared for clinical and pathological features, stage, surgical outcome, mortality and survival.
Statistically, there was no significant difference between patients in both groups regarding mortality (p=0.661), adjuvant chemotherapy (p 0.661), and radiation (p=1.000). However, there was significant difference in the degree of lymph node dissection employed (p=0.002) and the number of positive lymph nodes resected (p=0.038) between the two groups. The odds of death at five years for patients who had a D0 dissection was three times greater (odds ratio 2.78; (95%CI 1.33-5.82) than that for patients who had a D2 dissection, while for patients who had a D1 dissection the odds ratio was only 1.41 (95%CI 0.71-2.83) compared to D2-dissected patients.
Although no significant differences were found between proximal and distal gastric cancer, the increased risk of death in D0- and D1-dissected patients clearly suggests an important role of radical D2 lymph node dissection in survival.
尽管胃癌(腺癌)的发病率随时间推移有所下降,但它仍是全球最常见的恶性肿瘤之一,近端肿瘤的预后往往更差。
比较近端(不包括贲门肿瘤)和远端胃癌的手术结果及预后。
回顾293例病例——209例远端胃癌和69例近端胃癌——比较其临床和病理特征、分期、手术结果、死亡率和生存率。
统计学上,两组患者在死亡率(p = 0.661)、辅助化疗(p = 0.661)和放疗(p = 1.000)方面无显著差异。然而,两组在淋巴结清扫程度(p = 0.002)和切除的阳性淋巴结数量(p = 0.038)上存在显著差异。进行D0清扫的患者五年死亡几率是进行D2清扫患者的三倍(优势比2.78;95%置信区间1.33 - 5.82),而与进行D2清扫的患者相比,进行D1清扫的患者优势比仅为1.41(95%置信区间0.71 - 2.83)。
尽管近端和远端胃癌之间未发现显著差异,但D0和D1清扫患者死亡风险增加清楚表明根治性D2淋巴结清扫对生存具有重要作用。